Funder
National Institutes of Health
ACADIA Pharmaceuticals
NIMH
NIAAA
NINDS
Boehringer Ingelheim
Rettsyndrome.org
Vanderbilt University Medical Center
Reference72 articles.
1. The druggable genome and support for target identification and validation in drug development;Finan;Sci Transl Med,2017
2. The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): Expression, function and involvement in schizophrenia;Harrison;J Psychopharmacol,2008
3. Targeting metabotropic glutamate receptors for novel treatments of schizophrenia;Maksymetz;Mol Brain,2017
4. Biological insights from 108 schizophrenia-associated genetic loci;Nature,2014
5. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia;Egan;Proc Natl Acad Sci U S A,2004
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献